SKYE
Skye Bioscience Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.66
-0.05 ▼ -6.61%
🌙 3월 13일 7:39 PM ET (한국 3/14 08:39)
$0.65
-0.01 ▼ -1.50%
| Index | - | P/E | - | EPS (ttm) | -1.41 | Insider Own | 37.98% | Shs Outstand | 0.03B | Perf Week | -8.34% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | -20.45% | Insider Trans | - | Shs Float | 0.02B | Perf Month | -8.92% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.32 | Inst Own | 13.32% | Short Float | 4.67% | Perf Quarter | -42.08% |
| Income | -0.06B | P/S | - | EPS this Y | 28.06% | Inst Trans | -11.48% | Short Ratio | 1.4 | Perf Half Y | -84.5% |
| Sales | 0.00B | P/B | 1.1 | EPS next 5Y | -0.61% | ROA | -110.66% | Short Interest | 0.97M | Perf YTD | -11.92% |
| Book/sh | 0.6 | P/C | 0.86 | EPS past 3/5Y | 45.62% 28.34% | ROE | -126.85% | 52W High | -88.52% ($5.75) | Perf Year | -72.77% |
| Cash/sh | 0.77 | P/FCF | - | Sales past 3/5Y | - | ROIC | -278.12% | 52W Low | 8.25% ($0.61) | Perf 3Y | -90.22% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -93.71% | Gross Margin | - | Volatility(W/M) | 12.51% 7.97% | Perf 5Y | -97.76% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.07 | Perf 10Y | -99.61% |
| Dividend Ex-Date | - | Quick Ratio | 3.3 | EPS Q/Q | -49.3% | Profit Margin | - | RSI (14) | 35.81 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.3 | Sales Q/Q | - | SMA20 | -11.45% ($0.75) | Beta | 2.84 | Target Price | $8.71 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -22.86% ($0.86) | Rel Volume | 0.44 | Prev Close | $0.71 |
| Employees | 12 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -21.17% - | SMA200 | -69.78% ($2.18) | Avg Volume(3M) | 0.69M | Price | $0.66 |
| IPO | 2014/11/26 | Option/Short | Yes/Yes | Trades | 490 | Volume | 307,414 | Change | -6.61% |
뉴스 로딩 중...